Bellevue Life Sciences Acquisition Corp.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on $403,780 over the previous period. Total operating expenses were $1,830,700.
Profit Margin
| 2020 | 0 | -23.81K | |
|---|---|---|---|
| 2021 | 0 | -3.30K | |
| 2022 | 0 | -35.38K | |
| 2023 | 0 | 403.78K |
BLAC Income Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 |
Operating exp. | ||||
Research and development | 0 | 0 | 0 | 0 |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 1.83M | 35.38K | 3.30K | 23.81K |
Operating income | -1.83M | -35.38K | -3.30K | -23.81K |
Other income (expenses), net | 2.77M | 2 | 2 | -2 |
Income before tax | 944.59K | -35.38K | -3.30K | -23.81K |
Income tax expense | 540.81K | 0 | 0 | -206.29K |
Net income | 403.78K | -35.38K | -3.30K | -23.81K |
Earnings per share | ||||
Basic EPS | 0.07 | -0.00 | -0.00 | -0.00 |
Diluted EPS | 0.07 | -0.00 | -0.00 | -0.00 |
| Data source | Data source |